NKX2-1-conditioned disorder — «brain–lung–thyroid» syndrome: results of a multicenter study
Authors:
- Валерия Алексеевна СтрельниковаВСВалерия Алексеевна Стрельникова
- Dmitry Yu. OvsyannikovDODmitry Yu. Ovsyannikov
- Ольга Борисовна КондаковаОКОльга Борисовна Кондакова
- Людмила Михайловна КузенковаЛКЛюдмила Михайловна Кузенкова
- Шамиль Абдулвахидович ГитиновШГШамиль Абдулвахидович Гитинов
- Irina V. GirutskayaIGIrina V. Girutskaya
- Валерий Викторович ГоревВГВалерий Викторович Горев
- Мария Александровна ЖестковаМЖМария Александровна Жесткова
- Надежда Ефимовна КравченкоНКНадежда Ефимовна Кравченко
- Екатерина Александровна МамаеваЕМЕкатерина Александровна Мамаева
- Semyon S. MezhinskySMSemyon S. Mezhinsky
- Александр Николаевич НиколишинАНАлександр Николаевич Николишин
Open Access
- 27 April 2024
- journal article
- research article
- Published by National Medical Research Center for Childrens Health in L.O. Badalyan Neurological Journal
- Vol. 5 (1) , 14-28
Abstract
Introduction. Brain–lung–thyroid syndrome (BLTS, choreoathetosis and congenital hypothyroidism with or without pulmonary dysfunction) is an autosomal dominant disorder associated with mutations of the NKX2-1 gene. A triad of symptoms from three organs (brain, lungs, thyroid gland) is manifested in 50% of patients, in other cases there is an incomplete phenotype of the disease. The most common manifestations are neurological. The aim of the study was to provide genetic, clinical, laboratory, and instrumental characteristics in BLTS patients with a clinical and morphological assessment of the phenotype. Materials and methods. Ten children from 9 families with identified mutations in the NKX2-1 gene were observed. Methods used: genealogical, Sanger sequencing, clinical and morphological assessment of the phenotype, examination of thyroid hormone levels, CT, MRI of the brain, CT of the chest, lung biopsy. Results. The article presents the results of molecular genetic analysis, family history, age of manifestation and diagnosis. 9 out of 10 children had damage to the central nervous system, thyroid gland, lungs, and one child had a combination of neurological pathology and hypothyroidism. Neurological pathology was represented by benign hereditary chorea (2 children), delayed motor development (8), muscular hypotension (7), ataxia (5), choreoathetosis (1), clonuses (1), seizures (1), hyperkinesis (3); respiratory — respiratory distress syndrome (RDS) of newborns (6), chronic respiratory failure (5), interstitial lung disease (6), bronchial asthma (1), chronic pneumonitis of infants (1), bronchiectasis (1). There are presented changes in computed tomograms of the lungs and during preforming CT, MRI of the brain. Typical developmental microanomalia included a protruding forehead, a wide tip of the nose, elongated narrow palpebral fissure, deep-set eyes, hypertelorism of the eyes, large rotated low-lying auricles, conical fingers. Conclusion. A combination of congenital hypothyroidism, neonatal RDS, heart disease, neurological disorders (hypotension, ataxia, delayed motor development, chorea), craniofacial dysmorphia is the basis for a molecular genetic examination to exclude BLTS.Keywords
This publication has 27 references indexed in Scilit:
- NK2 homeobox gene cluster: Functions and roles in human diseasesGenes & Diseases, 2023
- Is Benign Hereditary Chorea Really Benign? Brain‐Lung‐Thyroid Syndrome Caused by NKX2‐1 MutationsMovement Disorders Clinical Practice, 2018
- Heterogeneity of lung disease associated with NK2 homeobox 1 mutationsRespiratory Medicine, 2017
- A further case of brain-lung-thyroid syndrome with deletion proximal to NKX2-1European Journal of Medical Genetics, 2017
- Respiratory insufficiency in a newborn with congenital hypothyroidism due to a new mutation of TTF‐1/NKX2.1 genePediatric Pulmonology, 2013
- Choreoathetosis, congenital hypothyroidism and neonatal respiratory distress syndrome with intact NKX2‐1American Journal of Medical Genetics Part A, 2012
- Expanding the phenomenology of benign hereditary chorea: Evolution from chorea to myoclonus and dystoniaMovement Disorders, 2011
- NKX2-1mutations leading to surfactant protein promoter dysregulation cause interstitial lung disease in “Brain-Lung-Thyroid Syndrome”Human Mutation, 2010
- Brain-Thyroid-Lung syndrome: a patient with a severe multi-system disorder due to a de novo mutation in the thyroid transcription factor 1 geneEuropean Journal of Pediatrics, 2005
- Thyroid nuclear factor 1 (TTF‐1) contains a homeodomain and displays a novel DNA binding specificity.The EMBO Journal, 1990